Number of COVID-19 vaccine doses produced by Sinopharm BIBP 2021-2022
By the end of January, the Beijing Institute of Biological Products Co. Ltd. (BIBP), a subsidiary of Chinese pharmaceutical giant Sinopharm, had produced almost 2.3 billion COVID-19 vaccine doses, ranking it the second-largest manufacturer of COVID-19 vaccines in the country. Although most Sinopharm BIBP vaccines are used domestically within China, a large number of doses were also exported worldwide through sales and donations. The company also constructed production sites with local partners in a number of countries to enable vaccine productions locally.